A study was undertaken to see the spinal anaesthesia consequences in patients undergoing surgeries below navel region while using the local anaesthetics like levobupivacaine, bupivacaine and ropivacaine along with an additive nalbuphine
Phase 2
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/04/051813
- Lead Sponsor
- PSG Institute of medical sciences and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients acceptance,
Patients aged between 20 and 50 years,
ASA status 1 and 2 patients and
Patients undergoing elective infra umbilical surgeries under spinal anesthesia.
Exclusion Criteria
Absolute contraindication for spinal anesthesia,
Combined spinal-epidural anesthesia,
Known hypersensitivity or allergy to the study drugs,
Pregnancy and lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective of this study is to compare the duration of motor blockade of hyperbaric levobupivacaine, bupivacaine and ropivacaine with nalbuphine adjuvant.Timepoint: 1, 3, 5, 10, 15, 30, 60, 90, 120, 180, 240 and 300 minutes
- Secondary Outcome Measures
Name Time Method The secondary objective focusses on the 1.Duration of sensory blockade 2.Effect of drugs on intraoperative haemodynamics 3.Time of regression of spinal anaesthesia 4.Side effects and complications of the hyperbaric levobupivacaine, bupivacaine and ropivacaine with nalbuphine as an adjuvant.Timepoint: 1, 3, 5, 10, 15, 30, 60, 90, 120, 180, 240 and 300 minutes